Cutera, inc. provides response to fda inquiry

Brisbane, calif.--( business wire )--cutera, inc. (nasdaq: cutr) (“cutera” or the “company”), a leading provider of aesthetic and dermatology solutions, today disclosed that it has provided a response to a recent fda inquiry.

CUTR Ratings Summary

CUTR Quant Ranking